IO Biotech, Inc.
Cash Flow Statement
| Line Item | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-21.7M | $-21.2M | $-17.0M | $-20.1M | $-15.7M | $-18.5M | $-17.2M | $-21.3M |
| Depreciation & Amortization | $100.0K | $100.0K | $50.0K | $90.0K | $10.0K | $0 | $0 | — |
| Depreciation | $54.0K | $55.0K | $47.0K | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.0M | $1.6M | $1.9M | $1.7M | $2.4M | $1.4M | $1.6M | $1.3M |
| Net Cash from Operating Activities | $-16.0M | $-18.3M | $-14.7M | $-12.5M | $-13.3M | $-13.0M | $-20.8M | $-19.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $24.0K | $39.0K | $148.0K | $349.0K | $118.0K | $107.0K | $116.0K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-24.0K | $-39.0K | $-148.0K | $-349.0K | $-118.0K | $-107.0K | $-116.0K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | — | — | — | — | — | $187.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-16.0M | $-18.3M | $-14.8M | $-12.9M | $-13.5M | $-13.1M | $-21.0M | — |